Evidence map›Paper›PMID 39831303›Full record

ArticleNucleic acids research2025

An integrated approach for the accurate detection of HERV-K HML-2 transcription and protein synthesis.

Charles Gleason, Sandra N Terry, Matthew M Hernandez, Samson Jacob, David Fenyo, Jeffrey R Johnson, Gintaras Deikus, Nancy Francoeur, Aana Hahn, Robert Sebra and 4 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Charles GleasonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Sandra N TerryDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Matthew M HernandezDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Samson JacobInstitute for Systems Genetics, NYU Langone Health, NY, NY 10157, USA.
David FenyoDepartment of Biochemistry and Molecular Pharmacology, NYU Langone Health, NY, NY 10157, USA.
Jeffrey R JohnsonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Gintaras DeikusDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Nancy FrancoeurDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Aana HahnDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Robert SebraDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Dmitriy ZamarinIcahn Genomics Institute, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Henrik MolinaProteomics Resource Center, The Rockefeller University, NY, NY 10065, USA.
Viviana SimonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.
Lubbertus C F MulderDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, NY, NY 10029, USA.ORCID 0009-0004-1731-2796

Funding

Determinants of HIV latency in CD4+ T lymphocytesR01AI179598 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Viviana A Simon · 2024 to 2026
$2.5M
Cellular Determinants and Function Consequences of PP2A-B56 Degradation by HIV-1 VifR01AI167691 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Jeffrey R Johnson · 2023 to 2026
$2.2M
HERV proteogenomics of narcotic-driven HIV latencyR61DA058294 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, LUBBERTUS C · 2023 to 2025
$2.2M
Impact of HERV-K expression on HIV-1 life cycleR01GM113886 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, LUBBERTUS C · 2014 to 2018
$1.8M
HERV proteogenomics of narcotic-driven HIV latencyR33DA058294 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LUBBERTUS C MULDER · 2026 to 2026
$722k
HIV-1-dependent HERV-K proteomeR21AI150355 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MULDER, LUBBERTUS C · 2020 to 2021
$484k
NIAID NIH HHS R01 AI167691NIAID NIH HHS R01 AI179598NIAID NIH HHS R21 AI150355NIDA NIH HHS R33 DA058294NIDA NIH HHS R61 DA058294NIGMS NIH HHS GM113886NIGMS NIH HHS R01 GM113886Parker Institute for Cancer Immunotherapy FD-16208
6 · The paper itself

Abstract

Human endogenous retroviruses (HERVs) occupy a large portion of the human genome. Most HERVs are transcriptionally silent, but they can be reactivated during pathological states such as viral infection and certain cancers. The HERV-K HML-2 clade includes elements that recently integrated have in the human germ line and often contain intact open reading frames that possibly support peptide and protein expression. Understanding HERV-K-host interactions and their potential as biomarkers is problematic due to the high similarity among different elements. Previously, we described a long-read single molecule real-time sequencing (PacBio) strategy to analyze HERV-K RNA expression profiles in different cell types. However, identifying HERV-K HML-2 proteins accurately is difficult without robust and reliable methods and reagents. Here we present a new approach to characterize the HML-2 elements that (a) are being translated and (b) produce enough protein to be detected and identified by mass spectrometry. Our data reveal that RNA expression profiling alone cannot accurately predict which HML-2 elements are responsible for protein production, as we observe several differences between the highest expressed RNAs and the elements that are the predominant source of HERV-K HML-2 protein synthesis. These studies represent an important advance toward untangling the complexity of HERV-K-host interactions.

Indexed as

Endogenous RetrovirusesProtein BiosynthesisTranscription, GeneticHumansOpen Reading Frames

Identifiers

PMID39831303
PMCPMC11744191

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.